Publications by authors named "J L Sears"

Background: Choroidal neovascular membranes (CNVM) associated with optic nerve head drusen (ONHD) are rare but vision threatening. A variety of treatments, including laser photocoagulation, subretinal surgery, and anti-VEGF injections, are effective but pose risks, particularly in pediatric patients, underscoring the need for a comprehensive review.

Methods: A systematic review was conducted using PubMed, Embase, and Web of Science.

View Article and Find Full Text PDF

Hereditary vitreoretinopathies (HVRs), also known as hereditary vitreoretinal degenerations comprise a heterogeneous group of inherited disorders of the retina and vitreous, collectively and variably characterised by vitreal abnormalities, such as fibrillary condensations, liquefaction or membranes, as well as peripheral retinal abnormalities, vascular changes in some, an increased risk of retinal detachment and early-onset cataract formation. The pathology often involves the vitreoretinal interface in some, while the major underlying abnormality is vascular in others. Recent advances in molecular diagnosis and identification of the responsible genes and have improved our understanding of the pathogenesis, risks and management of the HVRs.

View Article and Find Full Text PDF
Article Synopsis
  • A study examined long-term opioid prescribing patterns among workers after work-related injuries, focusing on those who had received opioids before their injury.
  • The research found that a significant number of workers continued to receive opioids after their injury, especially if they had been prescribed opioids in the three months leading up to the injury.
  • Results indicated that 34% of workers with prior opioid prescriptions were still receiving opioids 9-12 months after their injury, compared to only 7% of those without prior use, highlighting the need for healthcare providers to consider a patient’s history with opioids when treating work injuries.
View Article and Find Full Text PDF

Purpose: To evaluate the clinical outcomes and prognostic factors in unilateral Coats disease in the era of anti-VEGF therapy.

Design: Global, multicenter, retrospective case series.

Subjects: 656 eyes of 656 subjects with Coats disease were included in this study.

View Article and Find Full Text PDF

RA-0003022 () was identified as a high-quality covalent chemical probe for nsP2 cysteine protease (nsP2pro). Isoxazole covalently captured the active site C478 and inactivated the enzyme with a / ratio of 6000 Ms. A negative control analog RA-0025453 () retained the covalent warhead but demonstrated >100-fold decrease in enzyme inhibition.

View Article and Find Full Text PDF